News | Radiation Dose Management | February 01, 2018

EHRA Highlights Occupational Risk of Radiation Exposure in Electrophysiology Procedures

Stereotaxis technology included in recommendations to reduce fluoroscopy exposure and described as allowing “near zero exposure” to electrophysiologists

EHRA Highlights Occupational Risk of Radiation Exposure in Electrophysiology Procedures

February 1, 2018 –Stereotaxis, who makes innovative robotic technologies for the treatment of cardiac arrhythmias, announced that the European Heart Rhythm Association (EHRA) has published a consensus document endorsed by the Heart Rhythm Society (HRS) highlighting the occupational risk of radiation exposure in the electrophysiology laboratory and presenting several ways to reduce that exposure.

The occupational hazards to physicians and cath lab workers have been well documented in the literature. The EHRA consensus document states that “electrophysiology and training in electrophysiology may be associated with significant occupational radiation exposure.” Included in a list of recommendations for reduction of fluoroscopy exposure is the use of remote navigation systems such as the Niobe magnetic navigation system from Stereotaxis.

Unlike most recommendations, which reduce radiation exposure, the EHRA consensus document describes remote navigation systems as allowing for “near zero exposure to operator(s).”  The paper states that personnel in the electrophysiology laboratory who are positioned in the control room are protected by both shielding and distance from the X-ray beam, and that radiation exposure in the control room is 1,000 times lower than that seen in the operating room. During robotic navigation procedures utilizing Stereotaxis systems, physicians perform the ablation procedure from the control room, seated, unscrubbed, and protected.

“One of the primary benefits of the Stereotaxis system is reduction of harmful radiation to physicians, staff, and patients,” commented Sabine Ernst, co-author of the EHRA consensus statement. “The EHRA consensus statement, which was derived from evidence-based data from the literature, recognizes the Niobe remote navigation system for its contribution to making the electrophysiology lab safer by reducing radiation.”

The EHRA consensus paper adds to the list of clinical publications that have documented the significant risk of radiation exposure for physicians that perform interventional procedures. A study on interventional physicians with brain tumors found that 85 percent of tumors were in the left side of the brain as opposed to the right side, as the physicians usually stand with their left side closer to the X-ray source. It has also been reported that occupational radiation increased the risk for physician and cath lab workers for skin lesions, cataracts and cancer.

The most common method used by healthcare professionals to protect against radiation exposure while in the electrophysiology lab is the wearing of lead aprons and protective gear. Protective lead aprons may weigh over 20 pounds, and the long-term burden of this weight can lead to significant orthopedic problems. A recent survey was published that reported 49 percent of interventional cardiologists have suffered one or more orthopedic injuries as a direct result of their work in the cath lab, with 9 percent taking a health-related leave of absence.

Stereotaxis’ technology not only protects physicians and healthcare professionals from radiation exposure by removing them from the operating room, but has been shown to allow for reduced X-ray usage and associated radiation exposure for patients. While the EHRA consensus document focused on radiation exposure for healthcare professionals in the electrophysiology laboratory, the document also estimated that a patient undergoing a cardiac ablation procedure is exposed to 15.2 mSv of radiation per procedure. This value is the equivalent to approximately 760 standard chest X-rays (1 mSv = 50 chest X-rays). In an internal systematic review of peer-reviewed publications describing clinical experience with Stereotaxis’ remote magnetic navigation compared to manual ablation, comprising 20 publications and 4,567 patients in total, there was an average of 31 percent reduction in fluoroscopy time in robotic ablation procedures compared to manual ablation procedures. Stereotaxis continues to explore ways to advance its technology to allow even further reductions in radiation exposure for patients.

For more information: www.stereotaxis.com

Related Content

People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. 

Feature | Cath Lab | October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with pe
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders, suffers chest pain
News | Cath Lab | October 02, 2019 | Dave Fornell, Editor
October 2, 2019 — Democratic presidential candidate Sen.
Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival
News | Cath Lab | September 25, 2019
Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting stents in randomized...
Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Overlay Init